MedTrace Logo

Study to Investigate Effects of Different Therapies for the Treatment of Hypertension

NCT02637336 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2015-12-22

No results posted yet for this study

Summary

The aim of this study was to evaluate the acute cardiovascular responses in hypertensive individuals, in waking and sleeping periods after application of different non-pharmacological therapies for the control of blood pressure (BP). Randomly and random volunteers held a session of each therapy: Acupuncture, aerobic exercise, essential oil inhalation, and session control with a minimum interval of 72 hours between them. On the day of sessions the volunteers did not use antihypertensive medication. The variables measured in the survey were the blood pressure and heart rate variability (HRV). Descriptive statistical averaging procedures, standard deviation and standard error of mean were adopted. Two-way ANOVA for repeated measures was performed post-hoc Tukey. The level of the study significance was set at p \<0.05.

Conditions

Interventions

DEVICE

Acupuncture

Acupuncture in point 6 of the pericardium channel (neiguan) bilaterally

DEVICE

Aerobic exercise

aerobic exercise of moderate intensity

DEVICE

Aromatherapy

inhalation of eucalyptus essential oil

Sponsors & Collaborators

  • Fundação de Amparo à Ciência e Tecnologia de Pernambuco

    collaborator OTHER

  • Universidade Federal do vale do São Francisco

    lead OTHER

Principal Investigators

  • Marcus AF Silva · UNIVASF

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-07-31
Completion
2015-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02637336 on ClinicalTrials.gov